Chapter 31 Antiviral chemotherapy

Principles of Medical Biology

Volumn 9, Issue C, 1998, Pages 529-549

  Keating, Michael R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957073597     PISSN: 15692582     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1569-2582(97)80015-3     Document Type: Article

References (35)

1. Abrams D.I., Goldman A.I., Launer C., Korvick J.A., Neaton J.D., Crane L.R., Grodesky M., Wakefield S., Muth K., Kornegay S., Cohn D.L., Harris A., Luskin-Hawk R., Markowitz N., Sampson J.H., Thompson M., and Deyton L. A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. N. Engl. J. Med. 330 (1994) 657-662
2. Boyer P.J., Dillon M., Navaie M., Deveikis A., Keller M., O'Rourke S., and Bryson Y.J. Factors predictive of maternal-fetal transmission of HIV-1. JAMA 271 (1994) 1925-1930
3. Brunnell P.A. Chickenpox-Examining Our Options. N. Eng. J. Med. 325 (1991) 1577-1579
4. Bruns W.H., and Sandford G.R. Susceptibility of human herpesvirus 6 to antivirals in vitro. J. Inf. Dis. 162 (1990) 634-637
5. Caliendo A.M., and Hirsch M.S. Combination therapy for infection due to human immunodeficiency virus type 1. Clin. Inf. Dis. 18 (1994) 516-524
6. Crooks R.J., Jones D.A., and Fiddian A.P. Zoster-associated chronic pain: An overview of clinical trials with acyclovir. Scand. J. Infect. 78 (1991) 62-68
7. Douglas R.G. Prophylaxis and treatment of influenza. N. Engl. J. Med. 322 (1990) 443-450
8. Dunkle, L.M., Arvin, A.M., Whitley, R.J., Rotbart, H.A., Feder, H.M., Feldman, S., Gershon, A.A., Levy, M.L., Hayden, G.F., McGuirt, P.V., Harris, J., & Balfour, H.H. A controlled trial of acyclovir for chickenpox in normal children. N. Eng. J. Med. 325, 1539-1544.
9. Fischl M.A. Treatment of HIV disease in 1993/1994. AIDS Clin. Rev. (1993-1994) 167-187
10. Fletcher C.V., Englund J.A., Edelman C.K., Gross C.R., Dunn D.L., and Balfour H.H. Pharmacologic basis for high-dose oral acyclovir prophylaxis of cytomegalovirus disease in renal allograft recipients. Antimicr. Agents Chemoth. 35 (1991) 938-943
11. Gilbert B.E., and Knight V. Biochemistry and clinical applications of ribavirin. Antimicr. Agents Chemother. 30 (1986) 201-205
12. Guinan M.E. Oral acyclovir for treatment and suppression of genital herpes simplex virus infection. JAMA 255 (1986) 1747-1749
13. Hirsch M.S., and Schooley R.T. Resistance to antiviral drugs: The end of innocence. Editorial. N. Eng. J. Med. 320 (1989) 313-314
14. Holmes G.P., McCormick J.B., Trock S.C., Chase R.A., Lewis S.M., Mason C.A., Hall P.A., Brammer L.S., Perez-Oronoz G.I., McDonnell M.K., Paulissen J.P., Schonberger L.B., and Fisher-Hoch S.P. Lassa fever in the United States. N. Eng. J. Med. 323 (1990) 1120-1123
15. Huff M.C., Bean B., Balfour H.H., Laskin O.L., Connor J.D., Corey L., Bryson Y.J., and McGuirt P. Therapy of herpes zoster with oral acyclovir. Am. J. Med. 85 (1988) 84-89
16. Jabs D.A. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N. Eng. J. Med. 326 (1992) 213-220
17. Jacobson M.A., and Mills J. Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Ann. Int. Med. 108 (1988) 585-594
18. Jacobson M.A., and Oberg B. Mechanism of action, antiviral spectrum, and toxicity of foscarnet and other pyrophosphate analogs. In: Mills J., and Corey L. (Eds). Antiviral Chemotherapy: New Direction of Clinical Application and Research (1989), Elsevier, NY 211-217
19. In: Jonathan W.M., Gold E., Telzak E., and White D.A. (Eds). Management of the HIV-Infected Patient (1997), W.B. Saunders, Philadelphia
20. Kahn J.O., Lagakos S.W., Richman D.D., Cross A., Pettinelli C., Liou S., Brown M., Volberding P.A., Crumpacker C.S., Beali G., Beltangady M., Smaldone L., and Dolin R. A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. N. Eng. J. Med. 327 (1992) 581-587
21. McKendrick M., Wood M., Degreef H., Delescluse J., Decroix J., and deMaubeuge J. Reduction of zoster-associated pain (ZAP) by famciclovir. Seventh International Conference on Antiviral Research. Charleston, SC (1994)
22. McLeod G.X., and Hammer S.M. Zidovudine: five years later. Ann. Int. Med. 117 (1992) 487-501
23. Morse G.D., Shelton M.J., and O'Donnell A.M. Comparative pharmacokinetics of antiviral nucleoside analogues. Clin. Pharmacokinet. 24 (1993) 101-123
24. Perrillo R.P. Antiviral agents in the treatment of chronic viral hepatitis. Prog. in Liver Dis. 10 (1992) 283-309
25. Pue M.A., and Benet L.Z. Pharmacokinetics of famciclovir in man. Antiviral Chem. Chemoth. 4 (1993) 47-55
26. Rowe P.M. Another HIV drug. Lancet 343 (1994) 1351
27. Smith D.W., Frankel L.R., Mathers L.H., Tang A.T.S., Ariagno R.L., and Prober C.G. A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection. N. Eng. J. Med. 325 (1991) 24-29
28. Stankus B.J. Cytovene (Ganciclovir Sodium) (1992), Syntex Laboratories, Inc., Palo Alto, CA
29. Vere Hodge R.A. Famciclovir and penciclovir: The mode of action of famciclovir including its conversion to penciclovir. Antiviral Chem. Chemoth. 4 (1993) 67-84
30. Wallace M.R., Bowler W.A., Murray N.B., Brodine S.K., and Oldfield E.C. Oral acyclovir for adult varicella. Ann. Int. Med. 117 (1992) 358-363
31. Whitley R.J., and Gnann J.W. Acyclovir: A decade later. N. Eng. J. Med. 327 (1992) 782-789
32. Bean B. Antiviral therapy: Current concepts and practices. Clinical Microbiology Reviews 5 (1992) 146-182
33. In: De Vita V.T., Hellman S., and Rosenberg S.A. (Eds). AIDS: Etiology, Diagnosis, Treatment & Prevention. 4th ed (1997), Lippincott-Raven, Philadelphia
34. McLeod G.X., and Hammer S.M. Zidovudine: Five years later. Ann. Int. Med. 117 (1992) 487-501
35. Whitley R.J., and Gnann J.W. Acyclovir: A decade later. N. Eng. J. Med. 327 (1992) 782-789